Cargando…
A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
Despite that clinical trials have been examining the safety profile of coronavirus disease 2019 (COVID-19) vaccines, there are concerns about long-term side effects as the number of vaccinations increases. Herein, we report a case of new-onset renal-limited anti-myeloperoxidase (MPO) antineutrophil...
Autores principales: | Kim, Beop Chang, Kim, Han Seong, Han, Kum Hyun, Han, Sang Youb, Jo, Hyung Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259249/ https://www.ncbi.nlm.nih.gov/pubmed/35790206 http://dx.doi.org/10.3346/jkms.2022.37.e204 |
Ejemplares similares
-
MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
por: Eindhoven, Stefanie, et al.
Publicado: (2017) -
POS-851 MPO-ANCA ASSOCIATED VASCULITIS AFTER COVID-19
por: GARCIA-VEGA, A., et al.
Publicado: (2022) -
Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
por: O'Sullivan, Kim M., et al.
Publicado: (2021) -
Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis
por: Pacheco, Mariana, et al.
Publicado: (2021) -
Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)